Specialty Drug Distribution Market shall reach a value of $3,509.5 Million in 2027, growing with a CAGR of 12.06% during the forecast period of 2020 to 2027.

Specialty Drug Distibution Market Growth and Trends

The pharmacy share of revenue from speciality drugs, used to treat chronic diseases such as cancer, rheumatoid arthritis, and multiple sclerosis, is predicted to grow at a very high pace. Specialty drugs being medications oral or injectable in nature are featured by high complexity that require specialized handling, distribution, and temperature control. Rising incidence of chronic diseases conglomerated with increasing demand for specialty drugs on a worldwide basis are major factors driving the growth of the speciality drug distribution market. Improved logistics facilities along with efficient supply chain enhancing the distribution facilities are further contributing to the growth of the specialty drug distribution market, as the distributor provides patients with timely and easy access to safe prescription pharmaceuticals through purchase from a multitude of manufacturers, ensuring that the products are warehoused and transported in proper condition to several dispensing points, in compliance with federal and state regulations. Smaller full-line distributors are also important in the pharmaceutical ecosystem through serving independent customers or operating in selected geographic-/product-oriented niche markets. To increase revenue, minimize costs, and expand their channel role, large as well as small distributors are entering into innovative partnerships and providing services beyond core distribution, such as pharmacy support. In the self-warehousing model, distributors are delivering prescription pharmaceuticals to the retailer’s warehouse and then the retailer distributes these drugs to individual stores. Given its exposure to risk, challenges meeting distributor services and savings, and high-manufacture requirements, few customers opt for this model, whereas in the direct-to-store model, distributors take charge for delivering prescription drugs directly to retail stores. This model is more preferred by the market.

Restriction along distribution channels is to witness temporary hindrance to the growth of the market because brand manufacturers are using this for reducing generic competition by preventing generic companies from acquiring samples brand product.

Specialty Drug Distribution Market Regional Analysis

The size of the Speciality Drug Distribution Market in 2019 was $1.5 billion. It is estimated that it will grow at a CAGR of 11.5%. The market is divided into four central regions: North America, Asia Pacific, Europe, African Countries, and Latin America. North America, Canada and Brazil account for the maximum proportion. It continues to be dominant as in 2019. Its share was 40% of the global Specialty Drug Distribution Market due to healthcare development. The Asia Pacific, including Japan, India, China, South Korea, and Australia, continues to be one of the largest growing markets due to its increasing population. Japan, Australia, New Zealand, Singapore, and South Korea are the maximum revenue holders. European countries, including the UK, Germany, France, Spain, Netherlands, and Spain, continue to be the leading manufactures of the market. Mainly, countries like Switzerland, Norway, Netherlands, and Denmark hold the maximum share.

Specialty Drug Distribution Market Competition
Key companies operating in this industry are Amerisource, Mckesson, Cardinal Health, PHOENIX, Medipal Holdings, Alliance Healthcare, Celesio, Sinopharm, Accredo, Shanghai Pharma, Anda, Jointown, Max Pharma and Avella.

Coverage Highlights
• Specialty Drug Distribution Market Revenue Estimation and Forecast (2020 – 2027)
• Production Estimation and Forecast (2020 – 2027)
• Sales/Consumption Volume Estimation and Forecast (2020 – 2027)
• Breakdown of Revenue by Segments (2020 – 2027)
• Breakdown of Production by Segments (2020 – 2027)
• Breakdown of Sales Volume by Segments (2020 – 2027)
• Gross Margin and Profitability Analysis of Companies
• Business Trend and Expansion Analysis
• Import and Export Analysis

Specialty Drug Distribution Market Segmentation
Product Outlook (Revenue, USD Million, 2020 - 2027)
• Oncology
• Rheumatoid Arthritis
• Multiple Sclerosis
• Hemophilia
Application Outlook (Revenue, USD Million, 2020 - 2027)
• Retail
• Home Health
• Clinics
• Pharmacies
Country (Revenue, USD Million, 2020 - 2027)
• United States
• Canada
• Mexico
• France
• Germany
• Italy
• Spain
• United Kingdom
• Russia
• China
• India
• Philippines
• Malaysia
• Australia
• Austria
• South Korea
• Middle East
• Japan
• Africa
• Rest of World

Specialty Drug Distribution Market Companies
• Amerisource
• Mckesson
• Cardinal Health
• PHOENIX
• Medipal Holdings
• Alliance Healthcare
• Celesio
• Sinopharm
• Accredo
• Shanghai Pharma
• Anda
• Jointown
• Max Pharma
• Avella